Klotho modulation by tempol: a potential therapeutic axis in sepsis

Area of Science:

• Biomedical research
• Pathophysiology of sepsis
• Pharmacological interventions

Background:

• Sepsis triggers severe inflammatory and oxidative stress, leading to multiorgan failure.
• Imbalances in oxidant/antioxidant activity contribute to hyperinflammation, oxidation, and apoptosis in sepsis.
• Current treatments for sepsis-induced organ damage are limited.

Purpose of the Study:

• To investigate the protective effects of tempol against sepsis-induced cardiorenal injuries.
• To explore tempol's role in modulating Klotho expression during sepsis.
• To assess tempol's impact on inflammatory and oxidative stress markers.

Main Methods:

• A cecal ligation and puncture (CLP) model was used to induce sepsis in rodents.
• Survival rates, histopathology, and cardiorenal functions were evaluated.
• Levels of inflammatory markers (IL-6, TNF-α), oxidative stress markers (GSH, SOD), and apoptosis markers (caspase-3) were measured. Klotho and p38-MAPK expression was assessed via immunohistochemistry.

Main Results:

• CLP induced significant cardiorenal damage, high mortality, and elevated inflammatory markers.
• Tempol administration improved survival rates and ameliorated cardiorenal dysfunction.
• Tempol treatment reduced oxidative stress, suppressed inflammation (TNF-α, p38), decreased apoptosis (caspase-3), and increased Klotho expression.

Conclusions:

• Tempol demonstrates significant cardiorenal protective effects in a sepsis model.
• Tempol mitigates sepsis-induced organ damage by suppressing inflammation, oxidation, and apoptosis.
• Upregulation of Klotho and enhancement of antioxidant status are key mechanisms underlying tempol's efficacy.